These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 15461556)

  • 1. Recent advances in the development of multifactorial therapies for the treatment of traumatic brain injury.
    Vink R; Van Den Heuvel C
    Expert Opin Investig Drugs; 2004 Oct; 13(10):1263-74. PubMed ID: 15461556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multifunctional drugs for head injury.
    Vink R; Nimmo AJ
    Neurotherapeutics; 2009 Jan; 6(1):28-42. PubMed ID: 19110197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel therapies in development for the treatment of traumatic brain injury.
    Vink R; Nimmo AJ
    Expert Opin Investig Drugs; 2002 Oct; 11(10):1375-86. PubMed ID: 12387701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroprotection for traumatic brain injury.
    Loane DJ; Stoica BA; Faden AI
    Handb Clin Neurol; 2015; 127():343-66. PubMed ID: 25702227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An overview of new and novel pharmacotherapies for use in traumatic brain injury.
    Vink R; Nimmo AJ; Cernak I
    Clin Exp Pharmacol Physiol; 2001 Nov; 28(11):919-21. PubMed ID: 11703396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of magnesium in traumatic brain injury.
    Sen AP; Gulati A
    Neurotherapeutics; 2010 Jan; 7(1):91-9. PubMed ID: 20129501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dexanabinol as a treatment for traumatic brain injury: will another therapeutic promise be broken?
    Bedell EA; Prough DS
    Crit Care Med; 2002 Mar; 30(3):710-1. PubMed ID: 11990944
    [No Abstract]   [Full Text] [Related]  

  • 8. A review of neuroprotection pharmacology and therapies in patients with acute traumatic brain injury.
    McConeghy KW; Hatton J; Hughes L; Cook AM
    CNS Drugs; 2012 Jul; 26(7):613-36. PubMed ID: 22668124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of dexanabinol in severe traumatic brain injury: results of a phase III randomised, placebo-controlled, clinical trial.
    Maas AI; Murray G; Henney H; Kassem N; Legrand V; Mangelus M; Muizelaar JP; Stocchetti N; Knoller N;
    Lancet Neurol; 2006 Jan; 5(1):38-45. PubMed ID: 16361021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclosporin A attenuates acute mitochondrial dysfunction following traumatic brain injury.
    Sullivan PG; Thompson MB; Scheff SW
    Exp Neurol; 1999 Nov; 160(1):226-34. PubMed ID: 10630207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroprotection in traumatic brain injury: a complex struggle against the biology of nature.
    Schouten JW
    Curr Opin Crit Care; 2007 Apr; 13(2):134-42. PubMed ID: 17327733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progesterone as a neuroprotective factor in traumatic and ischemic brain injury.
    Sayeed I; Stein DG
    Prog Brain Res; 2009; 175():219-37. PubMed ID: 19660659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medical treatment and neuroprotection in traumatic brain injury.
    Clausen T; Bullock R
    Curr Pharm Des; 2001 Oct; 7(15):1517-32. PubMed ID: 11562296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Post-Injury Administration of Mitochondrial Uncouplers Increases Tissue Sparing and Improves Behavioral Outcome following Traumatic Brain Injury in Rodents.
    Pandya JD; Pauly JR; Nukala VN; Sebastian AH; Day KM; Korde AS; Maragos WF; Hall ED; Sullivan PG
    J Neurotrauma; 2007 May; 24(5):798-811. PubMed ID: 17518535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent advances in neuroprotection for treating traumatic brain injury.
    Cernak I
    Expert Opin Investig Drugs; 2006 Nov; 15(11):1371-81. PubMed ID: 17040197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progesterone neuroprotection: The background of clinical trial failure.
    Schumacher M; Denier C; Oudinet JP; Adams D; Guennoun R
    J Steroid Biochem Mol Biol; 2016 Jun; 160():53-66. PubMed ID: 26598278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Importance of screening logs in clinical trials for severe traumatic brain injury.
    Slieker FJ; Kompanje EJ; Murray GD; Ohman J; Stocchetti N; Teasdale SG; Maas AI;
    Neurosurgery; 2008 Jun; 62(6):1321-8; discussion 1328-9. PubMed ID: 18824999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progesterone in the clinical treatment of acute traumatic brain injury.
    Stein DG; Wright DW
    Expert Opin Investig Drugs; 2010 Jul; 19(7):847-57. PubMed ID: 20486864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A review of laboratory and clinical data supporting the safety and efficacy of cyclosporin A in traumatic brain injury.
    Lulic D; Burns J; Bae EC; van Loveren H; Borlongan CV
    Neurosurgery; 2011 May; 68(5):1172-85; discussion 1185-6. PubMed ID: 21307793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel therapeutic strategies for traumatic brain injury: acute antioxidant reinforcement.
    Fernández-Gajardo R; Matamala JM; Carrasco R; Gutiérrez R; Melo R; Rodrigo R
    CNS Drugs; 2014 Mar; 28(3):229-48. PubMed ID: 24532027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.